Loading...
Sector Pulse

Pharmaceutical Preparations leads, National Commercial Banks lags: where rotation is moving - Johnson & Johnson (JNJ)

Sector ranking shows Pharmaceutical Preparations near the top and National Commercial Banks near the bottom. The current spread is 5.26%, with rotation concentrated in a narrow set of names.

Feb 23, 2026Slot (ET): 2026-02-23 10:25 ETSession: opening-hoursUpdated dailyTrigger: Pharmaceutical Preparations leads while National Commercial Banks lags with 5.26% spread2 companies in focus
Back to analytics feedExplore companies
sector rotationpharmaceutical preparationsnational commercial banksequity sectors
Analyst commentary

What moved and why

Session breadth: 10 gainers vs 24 decliners. High-volume names: 10. Average move: -1.38%.

News catalysts

JPMNovo Nordisk selloff continues as stock gets hit with rating downgradesYahoo FinanceORCLDemolition work begins on Oracle Corp. Nashville HQ campusYahoo FinanceWMTIndian textile exporter Gokaldas expects margin lift after US trade dealYahoo Finance

Spread snapshot

Pharmaceutical Preparations is averaging 1.27% while National Commercial Banks is averaging -3.99%.

When this gap widens, portfolios usually reward relative-value positioning over broad beta.

Name-level confirmation

Leaders in Pharmaceutical Preparations are carrying most of the upside, while names in National Commercial Banks are contributing to downside breadth.

The key test is whether leadership expands beyond the first two names.

  • JNJ: 1.27%
  • JPM: -3.99%

What to monitor

If lagging sectors stabilize on volume, this rotation can cool quickly.

If leaders keep expanding breadth, the rotation can persist into the next session.

News catalysts in focus

Recent headline flow for JPM supports this setup: Novo Nordisk selloff continues as stock gets hit with rating downgrades. This is treated as a likely driver, pending follow-through confirmation.

A second catalyst from ORCL (Yahoo Finance) helps frame whether this move has broad confirmation or remains a single-name event.

  • JPM: Novo Nordisk selloff continues as stock gets hit with rating downgrades (Yahoo Finance, 2026-02-24, 2h ago)
  • ORCL: Demolition work begins on Oracle Corp. Nashville HQ campus (Yahoo Finance, 2026-02-24, 1h ago)
  • WMT: Indian textile exporter Gokaldas expects margin lift after US trade deal (Yahoo Finance, 2026-02-24, 3h ago)

Seven-day trend

Market breadth
Feb 13
Feb 17
Feb 18
Feb 19
Feb 20
Feb 23
GainersDeclinersHigh volume
Recent sessions table
DateGainersDeclinersHigh volumeAvg move
Feb 18, 202616910+0.10%
Feb 19, 202671510-0.32%
Feb 20, 2026151610-0.14%
Feb 23, 2026102210-1.00%

Top gainers

Momentum
LLY
+4.48%
WMT
+2.68%
PEP
+2.32%
XOM
+2.17%

Top decliners

Risk pockets
IBM-12.34%
ORCL-5.16%
ADBE-4.50%
CRM-4.00%

Sector rotation

Relative strength
Technology-4.66%
Services-Prepackaged Software-4.50%
National Commercial Banks-3.99%
Financials-3.42%

Markets in focus

Country concentration
US-1.38%
Companies in focus

Tickers linked to this briefing

Direct links to company profiles with market chart, filings, and news signals.

JNJ | US

JOHNSON & JOHNSON

$245.78 | +1.27% | vol 7.2M

JPM | US

JPMORGAN CHASE & CO

$297.88 | -3.99% | vol 11.2M

Methodology

Transparency
  • Coverage universe: 35 liquid public tickers tracked for 2026-02-23.
  • Publication mode: opening-hours. Reports are generated only when the corresponding market window is valid.
  • Ranking combines absolute move, relative volume, market breadth, and sector dispersion.
  • Each draft is checked against trigger logic and edited for readability before publication.
  • Method notes are intentionally high-level and avoid implementation-specific source details.

Disclaimer: This content is provided for informational purposes only and does not constitute investment, financial, legal, or tax advice. It is not an offer or solicitation to buy or sell any security. Market data may be delayed, incomplete, or inaccurate. Past performance is not indicative of future results. Always do your own research and consult a licensed financial adviser before making investment decisions.